Both afatinib and osimertinib are precision medications. They are used specifically for the treatment of NSCLC (NSCLC) in cases where there are mutational events in the EGFR (EGFR).This article aims to comprehensively compare afatinib and osimertinib. It highlights their unique characteristics and clinical applications.Afatinib functions by targeting the EGFR receptor, thus inhibition the signaling pathway that is responsible for tumor cell expansion and augment. As such, it is categorized as an EGFR tyrosine kinase inhibitor (TKI).Similar to afatinib, osimertinib is also an EGFR tyrosine kinase inhibitor (TKI). Osimertinib is designed…
